Maribavir
Maribavir is an orally available benzimidazole riboside compound with activity against cytomegalovirus (CMV). Maribavir is a selective ATP competitor of the viral UL97 kinase, which is involved in viral nuclear maturation events, such as viral DNA assembly and movement of viral capsids from the nucleus of infected cells. Maribavir has activity against strains of CMV that are resistant to standard anti-CMV agents.
| Catalog Number | T2162 |
| Alternative Name(s) | Benzimidavir , 1263W94 , BW1263W94 , GW257406X |
| Research Area | Others|||Proteases/Proteasome|||Microbiology/Virology |
| Molecular Formula | C15H19Cl2N3O4 |
| CAS# | 176161-24-3 |
| Purity | 99.85% |
| SMILES | CC(C)Nc1nc2cc(Cl)c(Cl)cc2n1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O |
| Size | 2 mg |
| Supplier Page | https://www.targetmol.com/compound/Maribavir |
| Additional Information | https://www.targetmol.com/datasheet/T2162 |